Compared with the control group, patients in non-SS group (P = 0.002, P = 0.11, P = 0.001) and SS group (P<0.001, P<0.001, P = 0.001) showed a significant increase in the mRNA expressions of IL-17A, IL-6 and IL-23. Here, IL6 is linked to synovial sarcoma.